ArticleThe Journal of clinical investigation2006

Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.

Roberto Piva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.